These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1974195)
1. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes. Mutlib AE; Nelson WL Drug Metab Dispos; 1990; 18(3):331-7. PubMed ID: 1974195 [TBL] [Abstract][Full Text] [Related]
2. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes. Mutlib AE; Nelson WL Drug Metab Dispos; 1990; 18(3):309-14. PubMed ID: 1974191 [TBL] [Abstract][Full Text] [Related]
3. Regiochemistry and enantioselectivity in the oxidative N-dealkylation of verapamil. Nelson WL; Olsen LD Drug Metab Dispos; 1988; 16(6):834-41. PubMed ID: 2907462 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil. Mutlib AE; Nelson WL J Pharmacol Exp Ther; 1990 Feb; 252(2):593-9. PubMed ID: 2313589 [TBL] [Abstract][Full Text] [Related]
5. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects. Nelson WL; Bartels MJ Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562 [TBL] [Abstract][Full Text] [Related]
6. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver. Nelson WL; Olsen LD; Beitner DB; Pallow RJ Drug Metab Dispos; 1988; 16(2):184-8. PubMed ID: 2898330 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Talaat RE; Nelson WL Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895 [TBL] [Abstract][Full Text] [Related]
8. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition. Marathe PH; Shen DD; Nelson WL Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of the calcium antagonist gallopamil in man. Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679 [TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of halazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyhalazepam. Lu XL; Yang SK Chirality; 1990; 2(1):1-9. PubMed ID: 2400636 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam. Lu XL; Yang SK Mol Pharmacol; 1989 Dec; 36(6):932-8. PubMed ID: 2601688 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans. Lavrijsen K; Van Houdt J; Van Dyck D; Hendrickx J; Lauwers W; Hurkmans R; Bockx M; Janssen C; Meuldermans W; Heykants J Drug Metab Dispos; 1990; 18(5):704-10. PubMed ID: 1981724 [TBL] [Abstract][Full Text] [Related]
14. Carbinolamines, imines, and oxazolidines from fluorinated propranolol analogs. (19)F NMR and mass spectral characterization and evidence for formation as intermediates in cytochrome P450-catalyzed N-dealkylation. Upthagrove AL; Nelson WL Drug Metab Dispos; 2001 Aug; 29(8):1114-22. PubMed ID: 11454730 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of antiparkinson agent dopazinol by rat liver microsomes. Vyas KP; Kari PH; Ramjit HG; Pitzenberger SM; Hichens M Drug Metab Dispos; 1990; 18(6):1025-30. PubMed ID: 1981508 [TBL] [Abstract][Full Text] [Related]
16. Biotransformation of aliphatic formamides: metabolites of (+-)-N-methyl-N-(1-methyl-3,3-diphenylpropyl) formamide in rats. Slatter JG; Mutlib AE; Abbott FS Biomed Environ Mass Spectrom; 1989 Sep; 18(9):690-701. PubMed ID: 2790257 [TBL] [Abstract][Full Text] [Related]
17. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride. Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931 [TBL] [Abstract][Full Text] [Related]
18. Influence of substrate configuration on chlorpheniramine N-demethylation by hepatic microsomes from rats, rabbits, and mice. Thompson JA; Shioshita GW Drug Metab Dispos; 1981; 9(1):5-9. PubMed ID: 6111432 [TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851 [TBL] [Abstract][Full Text] [Related]
20. Formation and reversibility of S-linked conjugates of N-(1-methyl-3,3-diphenylpropyl)isocyanate, an in vivo metabolite of N-(1-methyl-3,3-diphenylpropyl)formamaide, in rats. Mutlib AE; Talaat RE; Slatter JG; Abbott FS Drug Metab Dispos; 1990; 18(6):1038-45. PubMed ID: 1981510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]